Search Results for: CPRX
From BioHealth Investor Biotechnology NEURALSTEM INC [NRLS.OB] +19.05% REPROS THERAPEUTICS [RPRX] +16.52% CYTORI THERAPEUTICS [CYTX] +13.83% ADVENTRX PHARMACTL [ANX] +10.98% ARTES MEDICAL, INC....
Published:
From BioHealth Investor Biotechnology PIPEX PHARMACEUTICAL [PPXP.OB] +42.50% BIONOVO INC [BNVI.OB] +15.87% NEUROBIOLOGICAL TECH [NTII] +13.93% REPROS THERAPEUTICS [RPRX] +10.24% OBAGI MEDICAL [OMPI]...
Published:
by H.S. AyoubBioHealth Investor.com Biotechnology IDM PHARMA INC [IDMI] +45.33% NANOGEN INC [NGEN] +30.95% ENCYSIVE PHARMA [ENCY] +14.89% CARDIOVASCULAR BIOTH [CVBT.OB] +12.80% CYTRX CP [CYTR]...
Published:
Celator Pharmaceuticals has announced positive results from its Phase 3 trial of Vyxeos Liposome for Injection in patients with high-risk (secondary) acute myeloid leukemia.
Published:
Last Updated:
by H.S. AyoubBioHealth Investor.com Smart Investors Are Quietly Loading Up on These “Dividend Legends” If you want your portfolio to pay you cash like clockwork, it’s time to stop...
Published:
by H.S. AyoubBioHealth Investor.com Smart Investors Are Quietly Loading Up on These “Dividend Legends” If you want your portfolio to pay you cash like clockwork, it’s time to stop...
Published:
Index changes are generally speaking a fairly routine event. They can also create underlying moves in the companies added and deleted from them as money management firms often buy and sell shares,...
Published:
Last Updated:
by H.S. AyoubBioHealth Investor.com Smart Investors Are Quietly Loading Up on These “Dividend Legends” If you want your portfolio to pay you cash like clockwork, it’s time to stop...
Published:
ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or losers from the meeting can be divined ahead of time by these...
Published:
Last Updated:
The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their most recent drug trials.
Published:
Last Updated:
BMO Capital has downgraded its outlook for Capri Holdings to Market Perform.
Published:
If having a difficult to say and spell name wasn’t bad enough, issuing poor study results will do it. CombinatoRx, Inc. (CRXX-NASDAQ) just announced preliminary results of a Phase II clinical...
Published:
Citigroup has downgraded its outlook for Capri Holdings to Neutral.
Published:
Featured stocks include AMD, Snowflake and Zscaler.
Published:
The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society of Clinical Oncology (ASCO) is set to run from June 3 to June 7 in Chicago.
Published:
Last Updated: